Concentrix Corporation (NASDAQ: CNXC), a global technology and
services leader, today announced financial results for the fiscal
fourth quarter and fiscal year ended November 30, 2024.
|
Three Months Ended |
|
|
|
Fiscal Year Ended |
|
|
|
November 30, 2024 |
|
November 30, 2023 |
|
Change |
|
November 30, 2024 |
|
November 30, 2023 |
|
Change |
Revenue ($M) |
$ |
2,448.0 |
|
|
$ |
2,230.8 |
|
|
9.7 |
% |
|
$ |
9,618.9 |
|
|
$ |
7,114.7 |
|
|
35.2 |
% |
Operating income ($M) |
$ |
144.5 |
|
|
$ |
180.4 |
|
|
(19.9 |
)% |
|
$ |
596.4 |
|
|
$ |
661.3 |
|
|
(9.8 |
)% |
Non-GAAP operating income ($M)
(1) |
$ |
346.7 |
|
|
$ |
340.8 |
|
|
1.7 |
% |
|
$ |
1,317.9 |
|
|
$ |
1,010.0 |
|
|
30.5 |
% |
Operating margin |
|
5.9 |
% |
|
|
8.1 |
% |
|
-220 bps |
|
|
6.2 |
% |
|
|
9.3 |
% |
|
-310 bps |
Non-GAAP operating margin
(1) |
|
14.2 |
% |
|
|
15.3 |
% |
|
-110 bps |
|
|
13.7 |
% |
|
|
14.2 |
% |
|
-50 bps |
Net income ($M) |
$ |
115.7 |
|
|
$ |
69.5 |
|
|
66.5 |
% |
|
$ |
251.2 |
|
|
$ |
313.8 |
|
|
(19.9 |
)% |
Non-GAAP net income ($M)
(1) |
$ |
219.3 |
|
|
$ |
213.5 |
|
|
2.7 |
% |
|
$ |
772.3 |
|
|
$ |
630.7 |
|
|
22.5 |
% |
Adjusted EBITDA ($M) (1) |
$ |
402.9 |
|
|
$ |
397.9 |
|
|
1.3 |
% |
|
$ |
1,554.9 |
|
|
$ |
1,181.8 |
|
|
31.6 |
% |
Adjusted EBITDA margin
(1) |
|
16.5 |
% |
|
|
17.8 |
% |
|
-130 bps |
|
|
16.2 |
% |
|
|
16.6 |
% |
|
-40 bps |
Diluted earnings per common
share |
$ |
1.72 |
|
|
$ |
1.09 |
|
|
57.8 |
% |
|
$ |
3.71 |
|
|
$ |
5.70 |
|
|
(34.9 |
)% |
Non-GAAP diluted earnings per
common share (1) |
$ |
3.26 |
|
|
$ |
3.36 |
|
|
(3.0 |
)% |
|
$ |
11.42 |
|
|
$ |
11.45 |
|
|
(0.3 |
)% |
(1) See non-GAAP reconciliations included in the
accompanying financial tables for the reconciliation of each
non-GAAP measure to its most directly comparable GAAP
measure.Fourth Quarter Fiscal 2024 Highlights:
- Revenue of $2,448.0 million, an increase of 9.7% year-on-year
compared to revenue of $2,230.8 million in the prior year fourth
quarter. The Company grew revenue by 1.5% year-on-year on a pro
forma constant currency basis, at the top end of its guidance range
previously provided.
- Operating income of $144.5 million, or 5.9% of revenue,
compared with $180.4 million, or 8.1% of revenue in the prior year
fourth quarter.
- Non-GAAP operating income of $346.7 million, or 14.2% of
revenue, compared with $340.8 million, or 15.3% of revenue, in the
prior year fourth quarter. The change in non-GAAP operating margin
was primarily due to spending related to the productization and
commercialization of the Company’s new GenAI iX product suite.
- Adjusted EBITDA of $402.9 million, or 16.5% of revenue,
compared with $397.9 million, or 17.8% of revenue, in the prior
year fourth quarter.
- Cash flow from operations was $284.4 million in the quarter.
Adjusted free cash flow for the quarter was $218.7 million.
- Diluted earnings per common share (“EPS”) was $1.72 compared to
$1.09 in the prior year fourth quarter.
- Non-GAAP diluted EPS was $3.26 compared to $3.36 in the prior
year fourth quarter.
“We continue to achieve strong results across key
areas of growth in our business while repurchasing shares, reducing
our leverage and supporting our dividend,” said Chris Caldwell,
Concentrix President and CEO. “Strategically, we continue to
execute our plan for growth and market expansion while delivering
value to shareholders. We’ve seen our investments in our GenAI
product suite generate more than a dozen wins only weeks after
launch. And we continue to secure large, transformative client wins
that leverage our unique technology and service capabilities to
fuel our clients’ success. Entering 2025, we are delighted with our
strategic position and our opportunities for ongoing growth, margin
and free cash flow.”
Fiscal Year 2024 Highlights:
- Revenue of $9,618.9 million, an increase of 35.2% year-on-year
compared to revenue of $7,114.7 million in the prior fiscal year.
The Company grew revenue by 2.7% on a pro forma constant currency
basis, at the top end of its guidance range previously
provided.
- Operating income of $596.4 million, or 6.2% of revenue,
compared with $661.3 million, or 9.3% of revenue, in the prior
fiscal year.
- Non-GAAP operating income of $1,317.9 million, or 13.7% of
revenue, compared with $1,010.0 million, or 14.2% of revenue, in
the prior fiscal year.
- Adjusted EBITDA of $1,554.9 million, or 16.2% of revenue,
compared with $1,181.8 million, or 16.6% of revenue, in the prior
fiscal year.
- Cash flow from operations was $667.5 million in the fiscal
year. Adjusted free cash flow for the fiscal year was $474.5
million.
- Diluted EPS was $3.71 compared to $5.70 in the prior fiscal
year.
- Non-GAAP diluted EPS was $11.42 compared to $11.45 in the prior
fiscal year.
- Returned approximately $220 million to shareholders through
dividends and share repurchases while reducing debt by
approximately $209 million.
Quarterly Dividend and Share Repurchase
Program:
- The Company paid a $0.33275 per share quarterly dividend on
November 5, 2024. The Company’s Board of Directors has declared a
quarterly dividend of $0.33275 per share payable on February 11,
2025, to shareholders of record at the close of business on January
31, 2025.
- The Company repurchased 0.7 million shares in the fourth
quarter at a cost of $34.0 million under its previously announced
share repurchase program at an average cost of $49.46 per
share.
In addition, the Board of Directors has extended
the Company’s share repurchase program by authorizing an increase
of the amount remaining for share repurchases under the program to
$600 million.
First Quarter and Full Year Fiscal 2025
Outlook:
The following statements are based on the Company’s
current expectations for the first quarter and full year fiscal
2025. Non-GAAP financial measures exclude the impact of
acquisition-related and integration expenses, amortization of
intangible assets, depreciation, share-based compensation, and the
related tax effects thereon. The non-GAAP EPS guidance assumes no
impact from changes in acquisition contingent consideration and
foreign currency losses (gains), net included in other expense
(income), net. These statements are forward-looking and actual
results may differ materially.
First Quarter Fiscal 2025 Expectations:
- First quarter reported revenue of $2.355 billion to $2.370
billion. Based on current exchange rates, our expectations assume
approximately a 200-basis point negative impact of foreign exchange
rates compared with the prior year period. Our guidance implies
constant currency revenue growth for the first quarter in the range
of 0% to 0.75%.
- Operating income of $137 million to $147 million and non-GAAP
operating income is expected to be in the range of $305 million to
$315 million.
- Non-GAAP EPS of $2.49 to $2.64, assuming approximately 64.1
million diluted common shares outstanding and approximately 5% of
net income attributable to participating securities.
- The effective tax rate is expected to approximate 25.5% to
26.5%.
Full Year 2025 Expectations:
- Full year reported revenue of $9.470 billion to $9.610 billion.
Based on current exchange rates, our expectations assume
approximately a 150-basis point negative impact of foreign exchange
rates compared with the prior year. Our guidance implies constant
currency revenue growth for the full year in the range of 0% to
1.5%.
- Operating income of $663 million to $703 million and non-GAAP
operating income is expected to be in the range of $1,300 million
to $1,340 million.
- Non-GAAP EPS of $11.18 to $11.77, assuming approximately 63.6
million diluted common shares outstanding and approximately 5% of
net income attributable to participating securities.
- The effective tax rate is expected to approximate 25.5% to
26.5%.
In addition, the Company expects to generate
approximately $625 million to $650 million of adjusted free cash
flow in fiscal year 2025.
The Company believes that a quantitative
reconciliation of the non-GAAP EPS outlook to the most directly
comparable GAAP measure cannot be provided without unreasonable
efforts due to (a) the inability to forecast future changes in
acquisition contingent consideration, which is based, in part, on
the future trading price of the Company’s common stock, and (b) the
inability to forecast future foreign currency losses (gains), net
included in other expense (income), net. For the same reason, the
Company is unable to address the probable significance of the
unavailable information, which may have a material impact on the
Company’s GAAP results.
The Company believes that a quantitative
reconciliation of the adjusted free cash flow outlook to the most
directly comparable GAAP measure cannot be provided without
unreasonable efforts due to uncertainty related to the future
changes in the Company’s factoring program and related timing of
those changes. For the same reason, the Company is unable to
address the probable significance of the unavailable information,
which may have a material impact on the Company’s GAAP results.
Conference Call and WebcastThe
Company will host a conference call for investors to review its
fourth quarter and full year fiscal 2024 financial results today at
5:00 p.m. (ET)/2:00 p.m. (PT).
The live conference call webcast will be available
in listen-only mode in the Investor Relations section of the
Company’s website under “Events and Presentations” at
https://ir.concentrix.com/events-and-presentations. A replay will
also be available on the website following the conference call.
About us: Experience the power of
ConcentrixConcentrix Corporation (NASDAQ: CNXC), a Fortune
500® company, is the global technology and services leader that
powers the world’s best brands, today and into the future. We’re
human-centered, tech-powered, intelligence-fueled. Every day, we
design, build, and run fully integrated, end-to-end solutions at
speed and scale across the entire enterprise, helping over 2,000
clients solve their toughest business challenges. Whether it’s
designing game-changing brand experiences, building and scaling
secure AI technologies, or running digital operations that deliver
global consistency with a local touch, we have it covered. At the
heart of everything we do lies a commitment to transforming the way
companies connect, interact, and grow. We’re here to redefine what
success means, delivering outcomes unimagined across every major
vertical in 70+ markets. Virtually everywhere. Visit concentrix.com
to learn more.
Use of Non-GAAP InformationIn
addition to disclosing financial results that are determined in
accordance with GAAP, we also disclose certain non-GAAP financial
information, including:
- Constant currency revenue growth, which is revenue growth
adjusted for the translation effect of foreign currencies so that
certain financial results can be viewed without the impact of
fluctuations in foreign currency exchange rates, thereby
facilitating period-to-period comparisons of our business
performance. Constant currency revenue growth is calculated by
translating the revenue of each fiscal year in the billing currency
to U.S. dollars using the comparable prior year’s currency
conversion rate in comparison to prior year’s revenue. Generally,
when the U.S. dollar either strengthens or weakens against other
currencies, revenue growth at constant currency rates or adjusting
for currency will be higher or lower than revenue growth reported
at actual exchange rates.
- Pro forma constant currency revenue growth, which is constant
currency revenue growth measured against the Company’s combined pro
forma results of operations as if the combination with Webhelp had
occurred on December 1, 2022.
- Non-GAAP operating income, which is operating income, adjusted
to exclude acquisition-related and integration expenses, including
related restructuring costs, step-up depreciation, amortization of
intangible assets, and share-based compensation.
- Non-GAAP operating margin, which is non-GAAP operating income,
as defined above, divided by revenue.
- Adjusted earnings before interest, taxes, depreciation, and
amortization, or adjusted EBITDA, which is non-GAAP operating
income, as defined above, plus depreciation (exclusive of step-up
depreciation).
- Adjusted EBITDA margin, which is adjusted EBITDA, as defined
above, divided by revenue.
- Non-GAAP net income, which is net income excluding the
tax-effected impact of acquisition-related and integration
expenses, including related restructuring costs, step-up
depreciation, amortization of intangible assets, share-based
compensation, imputed interest related to the sellers’ note issued
in connection with the combination with Webhelp (the “sellers’
note”), change in acquisition contingent consideration and foreign
currency losses (gains), net. Non-GAAP net income also excludes the
income tax effect of certain legal entity restructuring
activity.
- Free cash flow, which is cash flows from operating activities
less capital expenditures, and adjusted free cash flow, which is
free cash flow excluding the effect of changes in the outstanding
factoring balance. We believe that free cash flow is a meaningful
measure of cash flows since capital expenditures are a necessary
component of ongoing operations. We believe that adjusted free cash
flow is a meaningful measure of cash flows because it removes the
effect of factoring which changes the timing of the receipt of cash
for certain receivables. However, free cash flow and adjusted free
cash flow have limitations because they do not represent the
residual cash flow available for discretionary expenditures. For
example, free cash flow and adjusted free cash flow do not
incorporate payments for business acquisitions.
- Non-GAAP diluted EPS, which is diluted EPS excluding the per
share, tax-effected impact of acquisition-related and integration
expenses, including related restructuring costs, step-up
depreciation, amortization of intangible assets, share-based
compensation, imputed interest related to the sellers’ note, change
in acquisition contingent consideration and foreign currency losses
(gains), net. Non-GAAP EPS also excludes the per share income tax
effect of certain legal entity restructuring activity. Non-GAAP EPS
excludes net income attributable to participating securities and
the related per share, tax-effected impact of adjustments to net
income described above reflect only those amounts that are
attributable to common shareholders.
We believe that providing this additional
information is useful to the reader to better assess and understand
our base operating performance, especially when comparing results
with previous periods and for planning and forecasting in future
periods, primarily because management typically monitors the
business adjusted for these items in addition to GAAP results.
Management also uses these non-GAAP measures to establish
operational goals and, in some cases, for measuring performance for
compensation purposes. These non-GAAP financial measures exclude
amortization of intangible assets. Although intangible assets
contribute to our revenue generation, the amortization of
intangible assets does not directly relate to the services
performed for our clients. Additionally, intangible asset
amortization expense typically fluctuates based on the size and
timing of our acquisition activity. Accordingly, we believe
excluding the amortization of intangible assets, along with the
other non-GAAP adjustments, which neither relate to the ordinary
course of our business nor reflect our underlying business
performance, enhances our and our investors’ ability to compare our
past financial performance with its current performance and to
analyze underlying business performance and trends. These non-GAAP
financial measures also exclude share-based compensation expense.
Given the subjective assumptions and the variety of award types
that companies can use when calculating share-based compensation
expense, management believes this additional information allows
investors to make additional comparisons between our operating
results and those of our peers. As these non-GAAP financial
measures are not calculated in accordance with GAAP, they may not
necessarily be comparable to similarly titled measures employed by
other companies. These non-GAAP financial measures should not be
considered in isolation or as a substitute for the comparable GAAP
measures and should be used as a complement to, and in conjunction
with, data presented in accordance with GAAP.
Safe Harbor StatementThis news
release includes forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended.
Forward-looking statements include, but are not limited to,
statements regarding the Company’s expected future financial
condition, growth and profitability, results of operations,
including revenue and operating income, cash flows, and effective
tax rate, the Company’s market valuation, the future growth and
success of the Company’s capabilities and products portfolio, the
potential benefits associated with use of the Company’s generative
artificial intelligence and other products, including productivity
and engagement gains, investments, share repurchase and dividend
activity, capital allocation, debt repayment, business strategy,
product launches, foreign currency exchange rate fluctuations, and
statements that include words such as believe, expect, may, will,
provide, could, should, and other similar expressions. These
forward-looking statements are inherently uncertain and involve
substantial risks and uncertainties that could cause actual results
to differ materially from those expressed or implied by such
statements. Risks and uncertainties include, among other things:
risks related to general economic conditions, including consumer
demand, interest rates, inflation, supply chains, and the effects
of the conflicts in Ukraine and Gaza; cyberattacks on the Company’s
or its clients’ networks and information technology systems;
uncertainty around, and disruption from, new and emerging
technologies, including the adoption and utilization of generative
artificial intelligence; the failure of the Company’s staff and
contractors to adhere to the Company’s and its clients’ controls
and processes; the inability to protect personal and proprietary
information; the effects of communicable diseases or other public
health crises, natural disasters and adverse weather conditions;
geopolitical, economic and climate- or weather-related risks in
regions with a significant concentration of the Company’s
operations; the ability to successfully execute on the Company’s
strategy; the timing and success of product launches; competitive
conditions in the Company’s industry and consolidation of its
competitors; variability in demand by the Company’s clients or the
early termination of the Company’s client contracts; the level of
business activity of the Company’s clients and the market
acceptance and performance of their products and services; the
demand for end-to-end solutions and technology; damage to the
Company’s reputation through the actions or inactions of third
parties; changes in law, regulations, or regulatory guidance; the
operability of the Company’s communication services and information
technology systems and networks; risks related to our ability to
realize estimated cost savings, synergies, or other anticipated
benefits of our combination with Webhelp within the expected
timeframe; the loss of key personnel or the inability to attract
and retain staff with the skills and expertise needed for the
Company’s business; increases in the cost of labor; the inability
to successfully identify, complete, and integrate strategic
acquisitions or investments; higher than expected tax liabilities;
currency exchange rate fluctuations; investigative or legal
actions; and other factors contained in the Company’s Annual Report
on Form 10-K for the fiscal year ended November 30, 2023 filed with
the Securities and Exchange Commission and subsequent SEC filings.
The Company does not undertake a duty to update forward-looking
statements, which speak only as of the date on which they are
made.
Copyright 2025 Concentrix
Corporation. All rights reserved. Concentrix, Webhelp, the
Concentrix logo, and all other Concentrix company, product, and
services word and design marks and slogans are trademarks or
registered trademarks of Concentrix Corporation and its
subsidiaries. Other names and marks are the property of their
respective owners.
From Fortune ©2024 Fortune Media IP Limited. All
rights reserved. Used under license. Fortune and Fortune 500 are
registered trademarks of Fortune Media IP Limited and are used
under license. Fortune and Fortune Media IP Limited are not
affiliated with, and do not endorse the products or services of
Concentrix.
Investor
Contact:Sara BudaInvestor
RelationsConcentrix Corporationsara.buda@concentrix.com(617)
331-0955
|
|
|
|
CONCENTRIX CORPORATIONCONSOLIDATED BALANCE
SHEETS(currency and share amounts in thousands,
except par value) |
|
|
|
|
|
November 30,2024 |
|
November 30,2023 |
|
(unaudited) |
|
|
ASSETS |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
240,571 |
|
|
$ |
295,336 |
|
Accounts receivable, net |
|
1,926,737 |
|
|
|
1,888,890 |
|
Other current assets |
|
675,116 |
|
|
|
674,423 |
|
Total current assets |
|
2,842,424 |
|
|
|
2,858,649 |
|
Property and equipment,
net |
|
714,517 |
|
|
|
748,691 |
|
Goodwill |
|
4,986,967 |
|
|
|
5,078,668 |
|
Intangible assets, net |
|
2,286,940 |
|
|
|
2,804,965 |
|
Deferred tax assets |
|
218,396 |
|
|
|
72,333 |
|
Other assets |
|
942,194 |
|
|
|
928,521 |
|
Total assets |
$ |
11,991,438 |
|
|
$ |
12,491,827 |
|
|
|
|
|
LIABILITIES AND
EQUITY |
|
|
|
Current liabilities: |
|
|
|
Accounts payable |
$ |
209,812 |
|
|
$ |
243,565 |
|
Current portion of long-term debt |
|
2,522 |
|
|
|
2,313 |
|
Accrued compensation and benefits |
|
706,619 |
|
|
|
731,172 |
|
Other accrued liabilities |
|
977,314 |
|
|
|
1,016,406 |
|
Income taxes payable |
|
99,546 |
|
|
|
80,583 |
|
Total current liabilities |
|
1,995,813 |
|
|
|
2,074,039 |
|
Long-term debt, net |
|
4,733,056 |
|
|
|
4,939,712 |
|
Other long-term
liabilities |
|
910,271 |
|
|
|
920,536 |
|
Deferred tax liabilities |
|
312,574 |
|
|
|
414,246 |
|
Total liabilities |
|
7,951,714 |
|
|
|
8,348,533 |
|
Stockholders’ equity: |
|
|
|
Preferred stock, $0.0001 par value, 10,000 shares authorized and no
shares issued and outstanding as of November 30, 2024 and 2023,
respectively |
|
— |
|
|
|
— |
|
Common stock, $0.0001 par value, 250,000 shares authorized; 68,849
and 67,883 shares issued as of November 30, 2024 and 2023,
respectively, and 64,238 and 65,734 shares outstanding as of
November 30, 2024 and 2023, respectively |
|
7 |
|
|
|
7 |
|
Additional paid-in capital |
|
3,683,608 |
|
|
|
3,582,521 |
|
Treasury stock, 4,611 and 2,149 shares as of November 30, 2024 and
2023, respectively |
|
(421,449 |
) |
|
|
(271,968 |
) |
Retained earnings |
|
1,191,871 |
|
|
|
1,024,461 |
|
Accumulated other comprehensive loss |
|
(414,313 |
) |
|
|
(191,727 |
) |
Total stockholders’ equity |
|
4,039,724 |
|
|
|
4,143,294 |
|
Total liabilities and stockholders’ equity |
$ |
11,991,438 |
|
|
$ |
12,491,827 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONCENTRIX CORPORATIONCONSOLIDATED
STATEMENTS OF OPERATIONS(currency and share
amounts in thousands, except per share
amounts)(unaudited) |
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
Fiscal Year Ended |
|
|
|
November 30, 2024 |
|
November 30, 2023 |
|
% Change |
|
November 30, 2024 |
|
November 30, 2023 |
|
% Change |
Revenue |
|
|
|
|
|
|
|
|
|
|
|
Technology and consumer electronics |
$ |
685,841 |
|
|
$ |
656,741 |
|
4 |
% |
|
$ |
2,674,040 |
|
|
$ |
2,205,834 |
|
21 |
% |
Retail, travel and e-commerce |
|
616,337 |
|
|
|
512,816 |
|
20 |
% |
|
|
2,361,866 |
|
|
|
1,448,666 |
|
63 |
% |
Communications and media |
|
385,996 |
|
|
|
350,416 |
|
10 |
% |
|
|
1,527,922 |
|
|
|
1,117,694 |
|
37 |
% |
Banking, financial services and insurance |
|
360,025 |
|
|
|
323,465 |
|
11 |
% |
|
|
1,455,641 |
|
|
|
1,091,853 |
|
33 |
% |
Healthcare |
|
187,227 |
|
|
|
186,306 |
|
— |
% |
|
|
727,389 |
|
|
|
696,266 |
|
4 |
% |
Other |
|
212,598 |
|
|
|
201,018 |
|
6 |
% |
|
|
872,042 |
|
|
|
554,393 |
|
57 |
% |
Total revenue |
|
2,448,024 |
|
|
|
2,230,762 |
|
10 |
% |
|
|
9,618,900 |
|
|
|
7,114,706 |
|
35 |
% |
Cost of revenue |
|
1,577,427 |
|
|
|
1,407,905 |
|
12 |
% |
|
|
6,170,013 |
|
|
|
4,536,771 |
|
36 |
% |
Gross profit |
|
870,597 |
|
|
|
822,857 |
|
6 |
% |
|
|
3,448,887 |
|
|
|
2,577,935 |
|
34 |
% |
Selling, general and
administrative expenses |
|
726,061 |
|
|
|
642,410 |
|
13 |
% |
|
|
2,852,500 |
|
|
|
1,916,608 |
|
49 |
% |
Operating income |
|
144,536 |
|
|
|
180,447 |
|
(20 |
)% |
|
|
596,387 |
|
|
|
661,327 |
|
(10 |
)% |
Interest expense and finance
charges, net |
|
76,117 |
|
|
|
70,508 |
|
8 |
% |
|
|
321,828 |
|
|
|
201,004 |
|
60 |
% |
Other expense (income),
net |
|
(44,487 |
) |
|
|
32,829 |
|
(236 |
)% |
|
|
(24,715 |
) |
|
|
52,095 |
|
(147 |
)% |
Income before income
taxes |
|
112,906 |
|
|
|
77,110 |
|
46 |
% |
|
|
299,274 |
|
|
|
408,228 |
|
(27 |
)% |
Provision for income
taxes |
|
(2,744 |
) |
|
|
7,623 |
|
(136 |
)% |
|
|
48,057 |
|
|
|
94,386 |
|
(49 |
)% |
Net income |
$ |
115,650 |
|
|
$ |
69,487 |
|
66 |
% |
|
$ |
251,217 |
|
|
$ |
313,842 |
|
(20 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common
share: |
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
1.72 |
|
|
$ |
1.10 |
|
|
|
$ |
3.72 |
|
|
$ |
5.72 |
|
|
Diluted |
$ |
1.72 |
|
|
$ |
1.09 |
|
|
|
$ |
3.71 |
|
|
$ |
5.70 |
|
|
Weighted-average common shares
outstanding: |
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
64,315 |
|
|
|
61,845 |
|
|
|
|
64,977 |
|
|
|
53,801 |
|
|
Diluted |
|
64,354 |
|
|
|
61,957 |
|
|
|
|
65,074 |
|
|
|
54,010 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONCENTRIX CORPORATIONRECONCILIATION OF
GAAP TO NON-GAAP MEASURES(currency and share
amounts in thousands, except per share
amounts)(unaudited) |
|
|
|
|
|
Three Months Ended |
|
Fiscal Year Ended |
|
November 30, 2024 |
|
November 30, 2024 |
Revenue |
$ |
2,448,024 |
|
|
$ |
9,618,900 |
|
Pro forma revenue growth |
|
1.3 |
% |
|
|
1.4 |
% |
Foreign exchange impact |
|
0.2 |
% |
|
|
1.3 |
% |
Pro forma constant currency
revenue growth |
|
1.5 |
% |
|
|
2.7 |
% |
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Fiscal Year Ended |
|
November 30, 2024 |
|
November 30, 2023 |
|
November 30, 2024 |
|
November 30, 2023 |
Operating income |
$ |
144,536 |
|
$ |
180,447 |
|
$ |
596,387 |
|
$ |
661,327 |
Acquisition-related and integration expenses |
|
59,637 |
|
|
39,866 |
|
|
156,771 |
|
|
71,336 |
Step-up depreciation |
|
2,475 |
|
|
— |
|
|
9,907 |
|
|
— |
Amortization of intangibles |
|
110,098 |
|
|
96,636 |
|
|
458,925 |
|
|
214,832 |
Share-based compensation |
|
29,995 |
|
|
23,810 |
|
|
95,922 |
|
|
62,493 |
Non-GAAP operating income |
$ |
346,741 |
|
$ |
340,759 |
|
$ |
1,317,912 |
|
$ |
1,009,988 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Fiscal Year Ended |
|
November 30, 2024 |
|
November 30, 2023 |
|
November 30, 2024 |
|
November 30, 2023 |
Net income |
$ |
115,650 |
|
|
$ |
69,487 |
|
$ |
251,217 |
|
|
$ |
313,842 |
Interest expense and finance charges, net |
|
76,117 |
|
|
|
70,508 |
|
|
321,828 |
|
|
|
201,004 |
Provision for income taxes |
|
(2,744 |
) |
|
|
7,623 |
|
|
48,057 |
|
|
|
94,386 |
Other expense (income), net |
|
(44,487 |
) |
|
|
32,829 |
|
|
(24,715 |
) |
|
|
52,095 |
Acquisition-related and integration expenses |
|
59,637 |
|
|
|
39,866 |
|
|
156,771 |
|
|
|
71,336 |
Step-up depreciation |
|
2,475 |
|
|
|
— |
|
|
9,907 |
|
|
|
— |
Amortization of intangibles |
|
110,098 |
|
|
|
96,636 |
|
|
458,925 |
|
|
|
214,832 |
Share-based compensation |
|
29,995 |
|
|
|
23,810 |
|
|
95,922 |
|
|
|
62,493 |
Depreciation |
|
56,149 |
|
|
|
57,169 |
|
|
237,013 |
|
|
|
171,801 |
Adjusted EBITDA |
$ |
402,890 |
|
|
$ |
397,928 |
|
$ |
1,554,925 |
|
|
$ |
1,181,789 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Fiscal Year Ended |
|
November 30, 2024 |
|
November 30, 2023 |
|
November 30, 2024 |
|
November 30, 2023 |
Operating margin |
5.9 |
% |
|
8.1 |
% |
|
6.2 |
% |
|
9.3 |
% |
Non-GAAP operating margin |
14.2 |
% |
|
15.3 |
% |
|
13.7 |
% |
|
14.2 |
% |
Adjusted EBITDA margin |
16.5 |
% |
|
17.8 |
% |
|
16.2 |
% |
|
16.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Fiscal Year Ended |
|
November 30, 2024 |
|
November 30, 2023 |
|
November 30, 2024 |
|
November 30, 2023 |
Net income |
$ |
115,650 |
|
|
$ |
69,487 |
|
|
$ |
251,217 |
|
|
$ |
313,842 |
|
Acquisition-related and integration expenses |
|
59,637 |
|
|
|
39,866 |
|
|
|
156,771 |
|
|
|
71,336 |
|
Step-up depreciation |
|
2,475 |
|
|
|
— |
|
|
|
9,907 |
|
|
|
— |
|
Acquisition-related expenses included in interest expense and
finance charges, net (1) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
25,556 |
|
Acquisition-related expenses included in other expense (income),
net (1) |
|
— |
|
|
|
136 |
|
|
|
— |
|
|
|
14,629 |
|
Imputed interest related to sellers’ note included in interest
expense and finance charges, net |
|
4,279 |
|
|
|
2,998 |
|
|
|
16,895 |
|
|
|
2,998 |
|
Change in acquisition contingent consideration included in other
expense (income), net |
|
(18,182 |
) |
|
|
15,681 |
|
|
|
(29,268 |
) |
|
|
15,681 |
|
Foreign currency losses (gains), net (4) |
|
(27,486 |
) |
|
|
12,833 |
|
|
|
(1,850 |
) |
|
|
14,938 |
|
Amortization of intangibles |
|
110,098 |
|
|
|
96,636 |
|
|
|
458,925 |
|
|
|
214,832 |
|
Share-based compensation |
|
29,995 |
|
|
|
23,810 |
|
|
|
95,922 |
|
|
|
62,493 |
|
Income taxes related to the above (2) |
|
(39,515 |
) |
|
|
(47,990 |
) |
|
|
(173,963 |
) |
|
|
(105,616 |
) |
Income tax effect of legal entity restructuring |
|
(17,617 |
) |
|
|
— |
|
|
|
(12,254 |
) |
|
|
— |
|
Non-GAAP net income |
$ |
219,334 |
|
|
$ |
213,457 |
|
|
$ |
772,302 |
|
|
$ |
630,689 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Fiscal Year Ended |
|
November 30, 2024 |
|
November 30, 2023 |
|
November 30, 2024 |
|
November 30, 2023 |
Net income |
$ |
115,650 |
|
|
$ |
69,487 |
|
|
$ |
251,217 |
|
|
$ |
313,842 |
|
Less: net income allocated to participating securities |
|
(5,034 |
) |
|
|
(1,659 |
) |
|
|
(9,490 |
) |
|
|
(5,978 |
) |
Net income attributable to common
stockholders |
|
110,616 |
|
|
|
67,828 |
|
|
|
241,727 |
|
|
|
307,864 |
|
Acquisition-related and integration expenses allocated to common
stockholders |
|
57,041 |
|
|
|
38,914 |
|
|
|
150,849 |
|
|
|
69,977 |
|
Step-up depreciation allocated to common stockholders |
|
2,367 |
|
|
|
— |
|
|
|
9,533 |
|
|
|
— |
|
Acquisition-related expenses included in interest expense and
finance charges, net allocated to common stockholders (1) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
25,069 |
|
Acquisition-related expenses included in other expense (income),
net allocated to common stockholders (1) |
|
— |
|
|
|
133 |
|
|
|
— |
|
|
|
14,350 |
|
Imputed interest related to sellers' note included in interest
expense and finance charges, net allocated to common
stockholders |
|
4,093 |
|
|
|
2,926 |
|
|
|
16,257 |
|
|
|
2,941 |
|
Change in acquisition contingent consideration included in other
expense (income), net allocated to common stockholders |
|
(17,391 |
) |
|
|
15,307 |
|
|
|
(28,162 |
) |
|
|
15,382 |
|
Foreign currency losses (gains), net allocated to common
stockholders (4) |
|
(26,290 |
) |
|
|
12,527 |
|
|
|
(1,780 |
) |
|
|
14,653 |
|
Amortization of intangibles allocated to common stockholders |
|
105,306 |
|
|
|
94,329 |
|
|
|
441,589 |
|
|
|
210,740 |
|
Share-based compensation allocated to common stockholders |
|
28,689 |
|
|
|
23,242 |
|
|
|
92,298 |
|
|
|
61,303 |
|
Income taxes related to the above allocated to common stockholders
(2) |
|
(37,795 |
) |
|
|
(46,844 |
) |
|
|
(167,391 |
) |
|
|
(103,604 |
) |
Income tax effect of legal entity restructuring allocated to common
stockholders |
|
(16,850 |
) |
|
|
— |
|
|
|
(11,791 |
) |
|
|
— |
|
Non-GAAP net income
attributable to common stockholders |
$ |
209,786 |
|
|
$ |
208,362 |
|
|
$ |
743,129 |
|
|
$ |
618,675 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Fiscal Year Ended |
|
November 30, 2024 |
|
November 30, 2023 |
|
November 30, 2024 |
|
November 30, 2023 |
Diluted earnings per common share (“EPS”) (3) |
$ |
1.72 |
|
|
$ |
1.09 |
|
|
$ |
3.71 |
|
|
$ |
5.70 |
|
Acquisition-related and integration expenses |
|
0.89 |
|
|
|
0.63 |
|
|
|
2.32 |
|
|
|
1.30 |
|
Step-up depreciation |
|
0.04 |
|
|
|
— |
|
|
|
0.15 |
|
|
|
— |
|
Acquisition-related expenses included in interest expense and
finance charges, net (1) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.46 |
|
Acquisition-related expenses included in other expense (income),
net (1) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.27 |
|
Imputed interest related to sellers’ note included in interest
expense and finance charges, net |
|
0.06 |
|
|
|
0.05 |
|
|
|
0.25 |
|
|
|
0.05 |
|
Change in acquisition contingent consideration included in other
expense (income), net |
|
(0.27 |
) |
|
|
0.25 |
|
|
|
(0.43 |
) |
|
|
0.28 |
|
Foreign currency losses (gains), net (4) |
|
(0.41 |
) |
|
|
0.20 |
|
|
|
(0.03 |
) |
|
|
0.27 |
|
Amortization of intangibles |
|
1.64 |
|
|
|
1.52 |
|
|
|
6.79 |
|
|
|
3.90 |
|
Share-based compensation |
|
0.45 |
|
|
|
0.38 |
|
|
|
1.42 |
|
|
|
1.14 |
|
Income taxes related to the above (2) |
|
(0.60 |
) |
|
|
(0.76 |
) |
|
|
(2.58 |
) |
|
|
(1.92 |
) |
Income tax effect of legal entity restructuring |
|
(0.26 |
) |
|
|
— |
|
|
|
(0.18 |
) |
|
|
— |
|
Non-GAAP diluted EPS |
$ |
3.26 |
|
|
$ |
3.36 |
|
|
$ |
11.42 |
|
|
$ |
11.45 |
|
|
|
|
|
|
|
|
|
Weighted-average number of
common shares - diluted |
|
64,354 |
|
|
|
61,957 |
|
|
|
65,074 |
|
|
|
54,010 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Fiscal Year Ended |
|
November 30, 2024 |
|
November 30, 2023 |
|
November 30, 2024 |
|
November 30, 2023 |
Net cash provided by operating activities |
$ |
284,401 |
|
|
$ |
229,264 |
|
|
$ |
667,492 |
|
|
$ |
678,008 |
|
Purchases of property and
equipment |
|
(59,871 |
) |
|
|
(64,815 |
) |
|
|
(238,762 |
) |
|
|
(180,532 |
) |
Free cash flow |
$ |
224,530 |
|
|
$ |
164,449 |
|
|
$ |
428,730 |
|
|
$ |
497,476 |
|
Change in outstanding
factoring balances |
|
(5,844 |
) |
|
|
|
|
45,788 |
|
|
|
Adjusted free cash flow |
$ |
218,686 |
|
|
|
|
$ |
474,518 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forecast |
|
Three Months Ending February 28, 2025 |
|
Fiscal Year Ending November 30, 2025 |
|
Low |
|
High |
|
Low |
|
High |
Revenue |
$ |
2,355,000 |
|
|
$ |
2,370,000 |
|
|
$ |
9,470,000 |
|
|
$ |
9,610,000 |
|
Revenue growth, as reported under U.S. GAAP |
|
(2.0 |
)% |
|
|
(1.4 |
)% |
|
|
(1.5 |
)% |
|
|
— |
% |
Foreign exchange impact |
|
2.0 |
% |
|
|
2.1 |
% |
|
|
1.5 |
% |
|
|
1.5 |
% |
Constant currency revenue
growth |
|
— |
% |
|
|
0.75 |
% |
|
|
— |
% |
|
|
1.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forecast |
|
Three Months Ending February 28, 2025 |
|
Fiscal Year Ending November 30, 2025 |
|
Low |
|
High |
|
Low |
|
High |
Operating income |
$ |
137,000 |
|
$ |
147,000 |
|
$ |
662,500 |
|
$ |
702,500 |
Amortization of intangibles |
|
109,000 |
|
|
109,000 |
|
|
432,000 |
|
|
432,000 |
Share-based compensation |
|
30,000 |
|
|
30,000 |
|
|
129,500 |
|
|
129,500 |
Acquisition-related and integration expenses |
|
26,500 |
|
|
26,500 |
|
|
66,000 |
|
|
66,000 |
Step-up depreciation |
|
2,500 |
|
|
2,500 |
|
|
10,000 |
|
|
10,000 |
Non-GAAP operating income |
$ |
305,000 |
|
$ |
315,000 |
|
$ |
1,300,000 |
|
$ |
1,340,000 |
|
|
|
|
|
|
|
|
|
|
|
|
(1) Included in these amounts are a) bridge
financing fees expensed and interest expenses associated with the
senior notes, net of interest earnings on invested proceeds
incurred in advance of the combination with Webhelp and b) expenses
associated with non-designated call option contracts put in place
to hedge foreign exchange movements in connection with the
combination with Webhelp that are included within interest expense
and finance charges, net and other expense (income), net,
respectively, in the consolidated statement of operations.(2) The
tax effect of taxable and deductible non-GAAP adjustments was
calculated using the tax-deductible portion of the expenses and
applying the entity-specific, statutory tax rates applicable to
each item during the respective periods presented.(3) Diluted EPS
is calculated using the two-class method. The two-class method is
an earnings allocation proportional to the respective ownership
among holders of common stock and participating securities.
Restricted stock awards, and since the fourth quarter of fiscal
year 2023, certain restricted stock units granted to employees are
considered participating securities. For the purposes of
calculating diluted EPS, net income attributable to participating
securities was approximately 4.4% and 2.4% of net income,
respectively, for the three months ended November 30, 2024 and 2023
and 3.8% and 1.9% of net income, respectively, for the fiscal years
ended November 30, 2024 and 2023, and was excluded from total net
income to calculate net income attributable to common stockholders.
In addition, the non-GAAP adjustments allocated to common
stockholders were calculated based on the percentage of net income
attributable to common stockholders.(4) Foreign currency losses
(gains), net are included in other expense (income), net and
primarily consist of gains and losses recognized on the revaluation
and settlement of foreign currency transactions and realized and
unrealized gains and losses on derivative contracts that do not
qualify for hedge accounting.
Concentrix (NASDAQ:CNXC)
Historical Stock Chart
From Dec 2024 to Jan 2025
Concentrix (NASDAQ:CNXC)
Historical Stock Chart
From Jan 2024 to Jan 2025